RARA CRAFT DATABASE for FDA Medical Devices
510(k)K200112

FDA DEVICE FACTS

Zimmer Hip Joint Replacement

Zimmer GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 10, 2020PRODUCT CODELZO

Indications for use

Wagner Cone Prosthesis are indicated for:

• Noninflammatory degenerative joint disease (NIDJD), e.g., avascular necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis.

• Failed previous surgery where pain, deformity, or dysfunction persists.

• Optional use in revision: in some medical conditions (e.g., early revision when healthy and good bone stock exists), the surgeon may opt to use primary implants in a revision procedure. Wagner SL Revision Stem Lateral is indicated for:

• Revision of previously failed hip arthroplasty. The BIOLOX delta Ceramic Femoral Heads are modular components used in total hip arthroplasty and are indicated for the following:

• Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head, and nonunion of previous fractures of the femur.

• Patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral epiphysis.

• Patients suffering from disability due to previous fusion; patients with previously failed endoprostheses and/or total hip components in the operative extremity.

• Patients with acute femoral neck fractures. The BIOLOX OPTION Ceramic Femoral Head System is comprised of modular components used in primary or revision total hip arthroplasty and is indicated for the following:

• Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head, and nonunion of previous fractures of the femur.

• Patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral epiphysis.

• Patients suffering from disability due to previous fusion.

• Patients with previously failed endoprostheses and/or total hip components in the operative extremity.

• Patients with acute neck fractures. The Fitmore® Hip Stem is for total hip or hemi-hip arthroplasty and is indicated for the following conditions:

• Noninflammatory degenerative joint disease (NIDJD), e. g., avascular necrosis, osteoarthritis and inflammatory joint disease (IJD), e. g., rheumatoid arthritis.

• Failed previous hip surgery (not THA) where pain, deformity or dysfunction persists.

• Optional use in revision: in some medical conditions (e. g., early revision when healthy and good bone stock exists) the surgeon may opt to use primary implants in a revision procedure.

• This stem is for uncemented use only. Avenir® Müller Stem is intended for:

• Advanced wear of the joint due to degenerative, post-traumatic or rheumatic diseases.

• Failed previous hip surgery (not THA) where pain, deformity, or dysfunction persists.

• Optional use in revision: in some medical conditions (e.g., early revision when healthy and good bone stock exists), the surgeon may opt to use primary implants in a revision procedure.

• Acute traumatic fracture of the femoral head or neck.

• Avascular necrosis of the femoral head. Avenir® Müller Stems are for cementless use only. The Avenir® Cemented Hip Stem is intended for total or hemi hip arthroplasty with cemented applications for rehabilitating hips damaged as a result of:

• Advanced wear of the joint due to degenerative, post-traumatic, or rheumatic diseases

• Failed previous hip surgery including joint reconstruction (osteotomy), arthrodesis, hemiarthroplasty or total hip replacement (THR)

• Acute traumatic fracture of the femoral head or neck

• Avascular necrosis of the femoral head. Alloclassic® Zweymüller® SL/ SL Offset Femoral Stems are indicated for:

• Noninflammatory degenerative joint disease (NIDJD), e.g., avascular necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis.

• Failed previous surgery where pain, deformity, or dysfunction persists.

• Revision of previously failed hip arthroplasty.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026